Author

Namhee Lee

Observed name: N. Lee

Institution: SillaJen (South Korea)

Observed institution: SillaJen (South Korea)

ORCID: 0000-0001-5009-3696

Observed ORCID: 0000-0001-5009-3696

OpenAlex ID: A5042537186

Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment

2022 · Jee Soo Park, Myung Eun Lee, et al. · Biomedicines · 12

Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy

2022 · Yun-Hui Jeon, Namhee Lee, et al. · Biomedicines · 11

BAP1 as a predictive biomarker of therapeutic response to oncolytic vaccinia virus for metastatic renal cell carcinoma therapy

2025 · Jee Soo Park, Won Sik Jang, et al. · Cancer Immunology Immunotherapy · 7

CD55-displaying oncolytic vaccinia virus treated metastatic cancers by evading the effect of host innate and adaptive humoral responses

2026 · Eunhye Kim, Yeonsoo Yang, et al. · Molecular Therapy · 4

Oncolytic vaccinia virus JX-594 shows subtype-specific activity and candidate biomarkers in gastric cancer cell lines

2026 · Jee Hung Kim, YeLin Kim, et al. · Scientific Reports

Abstract 4321: Oncolytic virus exhibits potent antitumor and immunomodulatory effects in triple-negative breast cancer using syngeneic and PDX models

2026 · Yelin KIM, Jihye B Lee, et al. · Cancer Research

Abstract PS3-13-06: Antitumor activity of the oncolytic virus JX-594 in patient-derived xenograft models of triple-negative breast cancer

2026 · J. Lee, Y. Kim, et al. · Clinical Cancer Research

Works count: 7

Citation count: 34

H-index: 4

I10-index: 2